(Q61313261)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Leishmania major

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

Fabienne Tacchini-Cottier

2 January 2020

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Cindy Allenbach

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Pascal Launois

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

720-731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

The immunology of susceptibility and resistance to Leishmania major in mice

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Tumor necrosis factor (cachectin) in human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Cytokine profile and pathology in human leishmaniasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Tumour necrosis factor alpha and mucocutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Cytokine patterns in the pathogenesis of human leishmaniasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Pneumocystis carinii pneumonia following a second infusion of infliximab

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Inactivation of TNF signaling by rationally designed dominant-negative TNF variants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Characterization of tumor necrosis factor-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Macrophages induce neutrophil apoptosis through membrane TNF, a process amplified by Leishmania major

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

How TNF was recognized as a key mechanism of disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Kupffer Cell-Expressed Membrane-Bound TNF Mediates Melphalan Hepatotoxicity via Activation of Both TNF Receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Neutrophil apoptosis pathways and their modifications in inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Bacterial ingestion, tumor necrosis factor-alpha, and heat induce programmed cell death in activated neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Macrophage-induced neutrophil apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Membrane tumor necrosis factor confers partial protection to Listeria infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

[Visceral leishmaniasis related to infliximab administration]

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

A limiting dilution assay for quantifying Leishmania major in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Notch1 expression on T cells is not required for CD4+ T helper differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737662

7 January 2021

Identifiers

DOI

10.1002/EJI.200737662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18266271%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference